Search results
Results From The WOW.Com Content Network
MannKind Corp (NASDAQ: MNKD) is trading significantly lower Monday morning after the company announced the FDA issued a complete response to United Therapeutics regarding the New Drug Application ...
MNKD earnings call for the period ending September 30, 2024. ... Joining us today from MannKind are: chief executive officer, Michael Castagna; and chief financial officer, Chris Prentiss ...
MannKind Corporation (NASDAQ: MNKD) and United Therapeutics Corporation (NASDAQ: UTHR) have announced that the FDA has accepted for review the marketing application of Tyvaso DPI (inhaled ...
Founded in February 1991, the company's present form is a result of a 2003 merger of three companies owned by Alfred E. Mann: Pharmaceutical Discovery Corporation (PDC), the cancer vaccine developer CTL ImmunoTherapies, Inc., and its sister company Allecure Corp, which was developing an allergy vaccine technology.
Image source: The Motley Fool. MannKind (NASDAQ: MNKD) Q2 2024 Earnings Call Aug 07, 2024, 9:00 a.m. ET. Contents: Prepared Remarks. Questions and Answers. Call ...
Investors have waited for a long time for MannKind (NAS: MNKD) to get a partner. As the development of its inhaled insulin product, Afrezza, has dragged on, it seems a partner is always just ...
Today's Top U.S. News Story Attorneys are suing to keep 10 migrants out of Guantanamo Bay as others say they were abused there Civil rights attorneys are suing the Trump administration to prevent it from transferring 10 migrants detained in the U.S. to Guantanamo Bay, Cuba More »
Stocktwits is a social media platform designed for sharing ideas between investors, traders, and entrepreneurs. [1] Founded in 2008 by Howard Lindzon and Soren McBeth, it introduced the use of the cashtag, a way to group discussions around a stock symbol preceded by a dollar sign. [2]